Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN7 | P35236 | 5/20 | 0.52 |
| ▸ | HMGCR | P04035 | 3/20 | 0.52 |
| ▸ | RECQL | P46063 | 2/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | USP2 | O75604 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.43 |
| ▸ | BLM | P54132 | 1/20 | 0.43 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL129776 | 1.00 | PTPN7 (0.52) | PTPN7HMGCRRECQLTDP1TSHR | |
| SCHEMBL9361038 | 1.00 | PTPN7 (0.52) | PTPN7HMGCRRECQLTDP1TSHR | |
| SCHEMBL448226 | 1.00 | PTPN7 (0.52) | PTPN7HMGCRRECQLTDP1TSHR | |
| SCHEMBL128297 | 1.00 | PTPN7 (0.52) | PTPN7HMGCRRECQLTDP1TSHR | |
| SCHEMBL448860 | 1.00 | PTPN7 (0.52) | PTPN7HMGCRRECQLTDP1TSHR | |
| SCHEMBL126745 | 1.00 | PTPN7 (0.52) | PTPN7HMGCRRECQLTDP1TSHR | |
| SCHEMBL448474 | 1.00 | PTPN7 (0.52) | PTPN7HMGCRRECQLTDP1TSHR | |
| SCHEMBL128390 | 1.00 | — | — | |
| SCHEMBL130583 | 1.00 | PTPN7 (0.52) | PTPN7HMGCRRECQLTDP1TSHR | |
| SCHEMBL31423438 | 1.00 | PTPN7 (0.52) | PTPN7HMGCRRECQLTDP1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113388360-B | Two-component polyurethane adhesive capable of being rapidly cured in long opening time | 杭州之江新材料有限公司 | 2022-10-28 | — | — | CN | claimed |
| EP-4096442-A1 | SOLID ADSORBENT COMPOSITIONS FOR PURIFYING LIQUIDS | The Dallas Group of America, Inc. (US) | 2022-12-07 | — | — | EP | disclosed |
| CN-113388360-B | Two-component polyurethane adhesive capable of being rapidly cured in long opening time | 杭州之江新材料有限公司 | 2022-10-28 | — | — | CN | disclosed |
| CN-110791363-B | Fully synthetic cutting fluid and preparation method thereof | 佳化化学(上海)有限公司 | 2022-05-27 | — | — | CN | disclosed |
| CN-103772082-B | The method of aldehydes or ketones prepared by a kind of dioxygen oxidation alcohol | EAST CHINA NORMAL UNIVERSITY (CN) | 2016-01-20 | — | — | CN | disclosed |
| US-9029069-B2 | Resist underlayer film-forming composition and method for forming pattern | JSR CORPORATION (JP) | 2015-05-12 | — | — | US | disclosed |
| US-8859185-B2 | Resist underlayer film-forming composition | JSR CORPORATION (JP) | 2014-10-14 | — | — | US | disclosed |
| EP-1512397-B1 | O-SUBSTITUTED HYDROXYARYL DERIVATIVES | INST MED MOLECULAR DESIGN INC (JP) | 2014-10-08 | — | — | EP | disclosed |
| CN-103772082-A | Method for preparing aldehyde or ketone by oxidizing alcohol by using oxygen | UNIV EAST CHINA NORMAL | 2014-05-07 | — | — | CN | disclosed |
| CN-102336619-B | Method for preparing aldehyde or ketone by oxidizing alcohol with oxygen | UNIV EAST CHINA NORMAL | 2014-01-29 | — | — | CN | disclosed |
| EP-1512397-A1 | O-SUBSTITUTED HYDROXYARYL DERIVATIVES | Institute of Medicinal Molecular Design, Inc. (JP) | 2005-03-09 | — | — | EP | disclosed |
| EP-1512396-A1 | INHIBITORS AGAINST THE ACTIVATION OF AP-1 AND NFAT | Institute of Medicinal Molecular Design, Inc. (JP) | 2005-03-09 | — | — | EP | disclosed |
| EP-1510210-A1 | IMMUNITY-RELATED PROTEIN KINASE INHIBITORS | Institute of Medicinal Molecular Design, Inc. (JP) | 2005-03-02 | — | — | EP | disclosed |
| EP-1510207-A1 | THERAPEUTIC DRUG FOR DIABETES | Institute of Medicinal Molecular Design, Inc. (JP) | 2005-03-02 | — | — | EP | disclosed |
| US-20040259877-A1 | Inhibitors against the production and release of inflammatory cytokines | INSTITUTE OF MEDICINAL MOLECULAR DESIGN, INC. (JP) | 2004-12-23 | — | — | US | disclosed |
| EP-1352650-A1 | INHIBITORS AGAINST THE PRODUCTION AND RELEASE OF INFLAMMATORY CYTOKINES | Institute of Medicinal Molecular Design, Inc. (JP) | 2003-10-15 | — | — | EP | disclosed |
| EP-0374765-B1 | 2,3-Disubstituted-4-hydroxyquinoline derivatives and process for preparing the same | MEIJI SEIKA KAISHA (JP) | 1994-06-22 | — | — | EP | disclosed |
| US-5194617-A | Leukotriene antagonist, antiasthma, improved blood circulation to brain | MEIJI SEIKA KAISHA, LTD. (JP) | 1993-03-16 | — | — | US | disclosed |
| EP-0374765-A1 | 2,3-Disubstituted-4-hydroxyquinoline derivatives and process for preparing the same | MEIJI SEIKA KAISHA LTD. (JP) | 1990-06-27 | — | — | EP | disclosed |
| US-4877891-A | INTERMEDIATES FOR E7,Z-9-DODECADIENYL ACETATE | BASF AKTIENGESELLSCHAFT (DE) | 1989-10-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040259877-A1 | Inhibitors against the production and release of inflammatory cytokines | NFKBIA, IL1B, IKBKB | PTPN7 865/4885HMGCR 2007/4885RECQL 3716/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.